Genomics Insitute of the Novartis Research Foundation

Halozyme Therapeutics Inc, based in San Diego, CA, is dedicated to transforming the patient experience through innovative drug delivery technologies. With a focus on easing the burden of treatment and enhancing patient outcomes, the company boasts a robust commercial portfolio that underscores its commitment to patient-centric solutions. By leveraging disruptive technologies such as ENHANZE and various auto-injector and multi-dose pen systems, Halozyme aims to revolutionize how therapies are administered. The company prioritizes corporate responsibility, diversity, and inclusion as integral components of its mission to improve healthcare delivery. Generated from the website